Meyer B J, Gschwend S, Marx B, Amann F W
Departement für Innere Medizin, Universitätsspital Zürich.
Schweiz Med Wochenschr. 1992 Jan 18;122(3):70-2.
In a double-blind randomized trial 63 patients on the waiting list for coronary artery bypass grafting, with stable angina NYHA III and a positive stress test on triple (nitrates, beta- and calcium entry blockers) combination therapy, were studied for an additional antianginal effect of amiodarone over a period of 2 months. In the treatment group an increase in exercise duration and a decrease of the double product and of ST-depression were noted. Thus, amiodarone is an effective antianginal agent in patients with limiting angina pectoris on conventional triple therapy.